Genmab: Looking To Manage My Position Around Q3 Earnings

Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been roughly eight months since my last Genmab ( GMAB ) article , where I highlighted the company's robust pipeline progress, strategic partnerships, and a strong 2023 performance, led by DARZALEX and their new product, EPKINLY. Genmab's revenue a ...